Menu
Welcome

About The Event

The Center for Genetic Engineering and Biotechnology is pleased to invite researchers, authorities, specialists, health program managers, students, professionals, biopharmaceutical producers and businessmen who work to preserve the health of people with diabetes, to join us in the VI edition of the International Congress “Controlling diabetes and its most severe complications”, from August 31st to September 4th, 2022, at the Plaza América Convention Center, in Varadero, Matanzas, Cuba.

Read more
Information of interest

Relevant information to download

Our General Program

Check the general activities of the event program

Our Scientific Program

Stay up to date with event activities up to the minute

Augmented Reality App

You can obtain information in an attractive way about Heberprot and other products

Get your certificate

Through your name you can obtain your certificate of participation

Schedule

Our Scientific Program

31/08/2022

Invitation

9:00 am - 5:30 pm

Arrival at the hotel and accreditation

31/08/2022

Invitation

2:00 pm - 3:00 pm

Launch

31/08/2022

Invitation

6:00 pm - 10:00 pm

Dinner

31/08/2022

Invitation

7:30 pm - 9:30 pm

Welcome cocktail

31/08/2022

Invitation

9:30 pm - 10:00 pm

Organizing Committee meeting

01/09/2022

Invitation

7:00 am - 7:40 am

Breakfast

01/09/2022

Invitation

7:30 am - 8:00 am

Transfer to Plaza America

01/09/2022

Invitation

9:00 am - 11:00 am

Plenary lectures

01/09/2022

Invitation

11:00 am - 11:30 am

Coffee break

01/09/2022

Invitation

8:30 am - 9:00 am

Opening ceremony

01/09/2022

Ileydis Iglesias

Cuba
9:00 am - 9:30 am

An update of the Cuban program for the integral care of people with diabetes

01/09/2022

Douglas Villaroel

Bolivia
9:30 am - 10:00 am

The Burden of Diabetes: How IDF Meet the Challenges?

01/09/2022

Jianxun Jim Song

United States
10:30 am - 11:00 am

NAC1 Modulates autoinmune diabetes by suppressing regulatory T cell-mediated tolerance

01/09/2022

Jorge Berlanga

Cuba
10:00 am - 10:30 am

Epidermal growth factor: from the nech to the clinic

01/09/2022

Oscar Díaz Díaz

Cuba
11:30 am - 11:50 am

Prevalence of obesity and dysglycemia in Cuba 2019-21

01/09/2022

Eduardo Cabrera Rode

Cuba
11:50 am - 12:10 pm

Non-invasive strategies for the identification of the risk of diabetes and prediabetes

01/09/2022

Pavel Weber

Czechia
12:10 pm - 12:30 pm

Obesity and diabetes- DIABESITY- two inseparable companions and their demanding treatment

01/09/2022

Ricardo Luna

Mexico
12:30 pm - 12:50 pm

Glycemic control in patients with obesity and diabetes

01/09/2022

Silvia E. Turcios Tristá

Cuba
1:10 pm - 1:25 pm

Role of obesity and diabetes in thyroid cancer

01/09/2022

Invitation

1:25 pm - 1:30 pm

General discussion

01/09/2022

Devendra Agrawal

United States
11:30 am - 11:50 am

Heterogeneity of Fibroblasts in Chronic Non-healing Diabetic Foot Ulcer: Therapeutic Potential to Enhance Wound Healing

01/09/2022

Subrata Chakrabarti

Canada
11:50 am - 12:10 pm

Development of a serum lncRNA-based assay for the diagnosis and assessment of progression of diabetic retinopathy.

01/09/2022

Jorge Berlanga

Cuba
12:10 pm - 12:30 pm

Adoptive Transfer

01/09/2022

Aristidis Veves

United States
12:50 pm - 1:10 pm

Single Cell Skin Transcriptomic Analysis in Patients with Healing and Non-Healing Diabetic Foot Ulcers: Lessons for Developing New Treatments

01/09/2022

Invitation

1:10 pm - 1:30 pm

General discussion

01/09/2022

Saymara Castillo Deprés

Cuba
11:30 am - 11:45 am

Heberprot-P use associated with predictive amputation index in the early treatment of diabetic foot ulcers in south african patients

01/09/2022

Katia Langton

Canada
11:45 am - 12:00 pm

Treating the Intrinsic Minus Foot:  Preventing the Forces Causing the Destruction of the Diabetic Foot

01/09/2022

José Agustín Llanes Barrios

Cuba
12:00 pm - 12:15 pm

A strategy to improve the integral care of diabetic foot ulcer patients in Carabobo, Venezuela

01/09/2022

Aurora Natacha Sancho Soutelo

Cuba
12:15 pm - 12:30 pm

Evolution of AB dermic burn with the use of Heberprot-P. A case

01/09/2022

Jhon Jairo Berrio

Colombia
12:30 pm - 12:45 pm

Clinical experience of hrecEGF in vascular ulcers

01/09/2022

Omaida Torres Herrera

Cuba
12:45 pm - 1:00 pm

Mortality rate for diabetic foot ulcer in Havana during 2010 – 2015

01/09/2022

Fermin Martinez

Mexico
1:00 pm - 1:15 pm

The Latin American system of San Elian for triage of diabetic foot attack

01/09/2022

Yaliexis Martínez Díaz

Cuba
1:15 pm - 1:30 pm

Minimal access surgery in diabetic foot

01/09/2022

Manuel Raices

Cuba
11:30 am - 11:45 am

Benefits of using Heberprot-P as part of a comprehensive care program for patients with diabetic foot, in the reduction of amputation risk and the reduction of direct and indirect costs in diabetic foot ulcer management.

01/09/2022

Carlos Alberto Carrillo

Colombia
11:45 am - 12:00 pm

Epiprot-P use in Colombia. 10 years of experience

01/09/2022

Julio Baldomero

Cuba
12:00 pm - 12:15 pm

Burden of the Primary Caregiver of the patient with DFU in Primary Health Care

01/09/2022

Penelope Montemayor

United States
12:15 pm - 12:30 pm

Implementing of programs aimed to the care of people with diabetes in a permanent scenario of COVID-19.

01/09/2022

Ana Ibis Conesa González

Cuba
12:30 pm - 12:45 pm

Risk foot detection program from the perspective of the three levels of healthcare

01/09/2022

Raúl Romay Buitrago

Cuba
12:45 pm - 1:00 pm

Results of the program for the integral care of people with diabetic foot ulcers at Camaguey province, during 2020 – 2021

01/09/2022

Invitation

1:15 pm - 1:30 pm

General discussion

01/09/2022

Invitation

3:00 pm - 6:00 pm

Poster session at Iberostar Bellavista Varadero Hotel

02/09/2022

Devendra Agrawal

United States
8:30 am - 9:00 am

Heterogeneity of Fibroblasts in Chronic Non-healing Diabetic Foot Ulcer: Therapeutic Potential to Enhance Wound Healing

02/09/2022

María del Carmen Domínguez

Cuba
9:00 am - 9:30 am

Jusvinza, inmunomodulatory peptide derived from human heat-shock protein 60, for treatment of hyperinflammation in COVID-19 patients

02/09/2022

Carlo Caravaggi

Italy
9:30 am - 9:50 am

Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening with severe diabetic foot ulcers

02/09/2022

José Fernández Montequín

Cuba
9:50 am - 10:10 am

Treating complex ulcers with Heberprot-P a change in wound healing perspectives

02/09/2022

Elof Eriksson

United States
10:00 am - 10:30 am

Platform wound device for protection, topical delivery and negative pressure wound therapy

02/09/2022

Damaris Hernández

Cuba
12:50 pm - 1:05 pm

Diabetes and the heart of women: does sex matter?

02/09/2022

José C. Jiménez

Mexico
11:30 am - 11:50 am

Insulin carbonylation due to oxidative stress induces loss of proteostasis, cell damage and insulin resistance in diabetic patients

02/09/2022

Renee Murray

United States
11:50 am - 12:10 pm

Reliability of Continuous Glucose Monitoring System in the Inpatient Setting

02/09/2022

Claudia A. García

Mexico
12:10 pm - 12:30 pm

Functional foods and bioactive components: an alternative in the medical nutritional therapy of the patient with type 2 diabetes

02/09/2022

Kalie L. Tommerdahl

United States
12:30 pm - 12:50 pm

Early Microvascular Complications in Type 1 and Type 2 Diabetes: Recent Develoents and Updates

02/09/2022

Jorge Berlanga

Cuba
11:00 am - 11:20 am

Epidermal Growth Factor Therapy Impact on Scar Tissue Resilience of Diabetic Lower Limbs Ulcers

02/09/2022

Yssel Mendoza

Cuba
11:40 am - 12:00 pm

Effect of recombinant human epidermal growth factor on diabetic foot ulcer healing, explained through variations in gene transcription

02/09/2022

Ariana García Ojalvo

Cuba
12:00 pm - 12:20 pm

Systemic effects of the intralesional treatment with epidermal growth factor (Heberprot-P) in patients with diabetic foot ulcers

02/09/2022

Ricardo Bringas Pérez

Cuba
12:20 pm - 12:40 pm

Sequence and structural analysis of the EGF/EGF-receptor complex

02/09/2022

Ouel Sosa Veras

Dominican Republic
12:40 pm - 1:00 pm

Heberprot-P therapy, experience in treating diabetic foot ulcers in Dominican Republic

02/09/2022

Elaine Castañeira Jorge

Cuba
12:00 pm - 12:15 pm

Results in Matanzas of the Program for the Integral care of diabetic foot ulcer patients during the COVID-19 pandemia. January 2019 – December 2021

02/09/2022

Gretel A. de Armas López

Cuba
11:00 am - 11:15 am

Heberprot-P in miocutaneus orthopedic problems

02/09/2022

Amel Alfonso Simón

Cuba
11:15 am - 11:45 am

Heberprot-P in the treatment of the ischemic ulcer with highputation risk

02/09/2022

Arístides García Herrera

Cuba
11:45 am - 12:00 pm

Endothelial dysfunction in diabetic patients with or without foot ulcers

02/09/2022

Carlo Caravaggi

Italy
12:15 pm - 12:30 pm

Modified Masquelet Tecnique in treatment of severe bone osteomyelitis of midfoot and ankle in Charcot Neuroathropathy: a retrospective observational study

02/09/2022

Pablo Boada

Mexico
12:30 pm - 12:45 pm

Platelet-rich plasma in the healing of ischemic lesions in patients with tibial vessel disease who are not candidates for revascularization surgery

02/09/2022

Moshe Kulikovsky

Israel
12:45 pm - 1:00 pm

The use of Autologous Blood Clot in Chronic Wounds

02/09/2022

Pablo Orellano

Uruguay
1:00 pm - 1:15 pm

Confinement and amputations

02/09/2022

Miguel Lopez

Spain
1:15 pm - 1:30 pm

Smart technology to improve the sustainable manufacturing of diabetes drugs

02/09/2022

Aida Rosa Hernández Díaz

Cuba
11:00 am - 11:15 am

Comprehensive Care Program for patients with diabetic foot ulcers in the province of Pinar del Río, Cuba

02/09/2022

Gabriel Picone

United States
11:15 am - 11:45 am

The Economic Impact of Diabetes and the COVID19 pandemic in the United States

02/09/2022

María M. Vázquez

Cuba
11:45 am - 12:00 pm

Cuba and Venezuela, comparison between two programs for the integral care of people with diabetes

02/09/2022

Timothy Lyons

United States
12:00 pm - 12:15 pm

Integrated pregnancy & post-partum care for women with diabetes in South Carolina

02/09/2022

Alfredo Aldama Figueroa

Cuba
12:15 pm - 12:30 pm

Nutritional Index as a prognostic value for clinical evolution of patients with DFU treated with Heberprot-P

02/09/2022

José Agustín Llanes Barrios

Cuba
12:30 pm - 12:45 pm

Primary, secondary care and Heberprot-P united in the reduction of hospitalization for diabetic foot in the province of Mayabeque, Cuba

02/09/2022

Israel Miranda Arnet

Cuba
12:45 pm - 1:00 pm

Introducing update elements at the program for the integral care of diabetic foot ulcer patients and Heberprot-P use, analysis in Havana

02/09/2022

Manuel Vera González

Cuba
1:00 pm - 1:15 pm

Education strategy for people with diabetes mellitus during pandemic times

03/09/2022

Invitation

12:30 pm - 1:00 pm

Congress balance and recognition to delegates by the Congress Organizing Committe

03/09/2022

Invitation

1:00 pm - 1:20 pm

Delegates opinions

03/09/2022

Invitation

1:20 pm - 1:30 pm

Farewell words

03/09/2022

Invitation

1:30 pm - 2:00 pm

Cultural performance

03/09/2022

Invitation

2:00 pm -

Return to the hotel

03/09/2022

Subrata Chakrabarti

Canada
11:00 am - 11:20 am

Lighting the dark mater – Non-coding RNAs in diabetic retinopathy

03/09/2022

Juan Vicente Méndez

Dominican Republic
11:20 am - 11:40 am

Heberprot-P use in Dominican Republic

03/09/2022

Yssel Mendoza

Cuba
11:40 am - 12:00 pm

CIGB 540: A novel candidate for hypertrophic scarring and keloids prevention

03/09/2022

Kyung-Hyun Cho

South Korea
12:00 pm - 12:20 pm

Efficacy comparison of human epidermal growth factor between Heberprot-P and Easyef in tissue regeneration and wound healing model of zebrafish and its embryo

03/09/2022

Keasha Guerrier

United States
8:30 am - 8:50 am

Measuring the effect of Diabetes Mellitus on patients with COVID-19 in varied zip codes across Long Island NY

03/09/2022

Marelys Yanes Quesada

Cuba
8:50 am - 9:10 am

Diabetes and COVID-19: where is the problem?

03/09/2022

Cossette Díaz

Cuba
9:10 am - 9:25 am

Post COVID-19 diabetes?

03/09/2022

Maura Pérez Recio

Cuba
9:25 am - 9:40 am

Diabetes mellitus and natural medicine: A national program with effective alternatives

03/09/2022

Maité Cabrera Gámez

Cuba
9:40 am - 9:55 am

Risk of diabetes in reproductive diseases

03/09/2022

Alina Acosta Cedeño

Cuba
9:55 am - 10:10 am

Dysglycemia and Vitamin D

03/09/2022

Daysi Antonia Navarro Despaigne

Cuba
10:10 am - 10:25 am

Dysglycemia and osteosarcopenia in the elderly

03/09/2022

Subrata Chakrabarti

Canada
8:50 am - 9:10 am

lncRNA ANRIL – a potential novel treatment target for diabetic nephropathy

03/09/2022

José C. Jiménez

Mexico
9:10 am - 9:30 am

Comparative analysis between cell therapies and the application of exosomal proteins in diabetic foot wounds

03/09/2022

Ayman Grada

United States
9:30 am - 9:50 am

Autologous Cultured Bone Marrow-Derived Mesenchymal Stem Cells in a Fibrin Spray to Treat Recalcitrant Venous Leg Ulcers: A Randomized Controlled Double-Blind Pilot Study

03/09/2022

Carlo Caravaggi

Italy
9:50 am - 10:10 am

Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening with severe diabetic foot ulcers

03/09/2022

Luigi Uccioli

Cuba
10:10 am - 10:30 am

New frontiers in Regenerative Medicine

03/09/2022

Jorge Rondón Labrada

Cuba
8:30 am - 8:45 am

Treatment with Heberprot-P of hand lessions in people with diabetes

03/09/2022

Maria Teresa Cacua

Colombia
8:45 am - 9:00 am

hrecEGF in venous ulcers. Our experience in a global vision

03/09/2022

Zulema Borges León

Cuba
9:00 am - 9:15 am

Benefits of Heberprot-P use in patients holding extremelly complex wounds

03/09/2022

Ysmar M. Carrillo

Venezuela
9:15 am - 9:30 am

Resultados del Programa Buen Vivir para diabéticos en la República bolivariana de Venezuela

03/09/2022

Rafael Vásquez

Dominican Republic
9:30 am - 9:45 am

Heberprot-P (How its use modified the main indicators of surgery services)

03/09/2022

Ayled Perez

Cuba
9:45 am - 10:00 am

Asintomatic perisferal arterial disease screening in people with diabetes mellitus type 2

03/09/2022

Rodolfo Valdés

Cuba
10:00 am - 10:15 am

Connection among high sugar level, immune system, COVID-19 and new cases of diabetes

03/09/2022

Lidia Ferrer Tasies

Spain
10:15 am - 10:30 am

rhEGF-DELOS nanovesicles: a reformulation of the recombinant human epidermal growth factor towards topical complex wound healing treatment

03/09/2022

Lilia T. González Cárdenas

Cuba
8:30 am - 8:45 am

Strengths of the Primary Health Care System in Cuba

03/09/2022

Antonio Martínez

United States
8:45 am - 9:00 am

The Remission of Type 2 Diabetes Through the Intermittent Diet and Fasting – The Successful Experience of the Patient

03/09/2022

Julio César Patiño Pérez

Cuba
9:00 am - 9:15 am

Results of the program for the integral care of people with diabetic foot ulcers at Holguin province, during 2020 – 2021

03/09/2022

Jeddú Cruz Hernández

Cuba
9:15 am - 9:30 am

Gestational diabetes program in Cuba

03/09/2022

Ileana Cubas Dueñas

Cuba
9:30 am - 9:45 am

An Exploratory Study of Itolizumab on the Preservation of Beta Cell Function in Adults with Recent-Onset Type 1 diabetes

03/09/2022

Israel Miranda Arnet

Cuba
9:45 am - 10:00 am

Coordination tasks in the comprehensive care program for diabetic foot ulcer patients with the use of Heberprot-P, Measuring their results in Dominican Republic

03/09/2022

Ileydis Iglesias

Cuba
10:15 am - 10:30 am

Vaccines and biotechnological products in Diabetes. country experience

04/09/2022

Invitation

7:00 am -

Breakfast

04/09/2022

Invitation

12:00 pm -

Room delivery

04/09/2022

Invitation

12:00 pm - 2:30 pm

Lunch

04/09/2022

Invitation

2:30 pm - 4:00 pm

Transfer to the provinces/Transfer to the airport

Sponsors

Our Event Sponsors

Gallery

Photos of moments of the day

See all